https://tonic.inserm.fr/wp-content/uploads/2019/09/equipe-femme-defaut-150x150.jpg
 

Fatima TENSAOUTI

CR

    Abstracts rédigés ou co-rédigés

  • > MR imaging predictor of survival in pediatric ependymoma patients after radiotherapy

    F. Tensaouti, A. Ducassou, L. Chaltiel, A. Sevely, S. Bolle, X. Muracciole, B. Coche-Dequant, C. Alapetite, S. Supiot, A. Huchet,V. Bernier, L. Claude, A.I. Bertozzi-Salamon, P. Péran, P. Payoux, A. Laprie.

    European SocieTy for Radiotherapy and Oncology (ESTRO) - VIENNE
  • > Subventricular zones: new key targets for glioblastoma treatment

    J. Khalifa, F. Tensaouti, A. Lusque, B. Plas, J.A. Lotterie, E. Uro-Coste, V. Lubrano, E. Cohen-Jonathan Moyal

    ESTRO - European SocieTy of RADIOTHERAPY&ONCOLOGY - TURIN
  • > Zones subventriculaires : de nouvelles cibles pour le traitement des glioblastomes

    J.Khalifa, F.Tensaouti, A.Lusque, B.Plas, J.A.Lotterie, A.Benouaich-Amiel, E.Uro-coste, V.Lubrano, É.Cohen-Jonathan Moyal

    SFRO- Sociéte Française de Radiothérapie Oncologique - PARIS
  • > Outcomes after Surgery and Adjuvant Therapy for Glioblastoma : Results of a Single Institution Retrospective Study

    V Lubrano, B Plas, J. Khalifa, F Tensaouti, JC Sol, E. Cohen-Jonathan Moyal

    Société Française de Neurochirurgie - MONTPELLIER
  • > Patterns of failure after radiotherapy in pediatric ependymoma: correlation with dose parameters.

    F.Tensaouti, A.Ducassou, S.Bolle, X.Muracciole, B.Coche-dequeant, L.Claude, S.Supiot, C.Alapetite, V.Bernier, A.Huchet, C.Kerr, E.Le Prise, G.Truc, E.Regnier, S.Chapet, A.Lisbona, G.Hangard, A.Laprie

    ESTRO - European SocieTy of RADIOTHERAPY&ONCOLOGY - TURIN

    Publications rédigées ou co-rédigées

  • > 37- Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma

    Tensaouti F, Ducassou A, Chaltiel L, Bolle S,Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L,Muracciole X, Supiot S,  Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R and Laprie A on behalf of the Radiotherapy Committee of the French Society for Childhood Cancer (SFCE), alias the French Paediatric Radiotherapy Group (GFRP)

    Frontiers in Oncology, June 2019 Volume 9 Article 531doi: 10.3389/fonc.2019.00531
  • > 35- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

    Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.

    BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
  • > 10- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

    Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.

    BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
  • > 25- Pediatric localized intra cranial ependymomas: a multicenter analysis of the children’s cancer french society (SFCE) analysis of the children’s cancer french society (SFCE)

    Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner B, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen T, Bertozzi A, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A

    Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173. doi: 10.1016/j.ijrobp.2018.05.036.
  • > 39- Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l’Enfant (SFCE) from 2000 to 2013.

    Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen TD, Bertozzi AI, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A;

    Pediatric French Radiation Oncologist Group (GFRP) and the French Society of Children With Cancer (SFCE). Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173. doi: 10.1016/j.ijrobp.2018.05.036. Epub 2018 May 24.
  • > 51- Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma.

    Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A; French Society for Childhood Cancer (SFCE).

    Radiother Oncol. 2018 Apr;127(1):103-107. doi: 10.1016/j.radonc.2018.02.008.
  • > 8- Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma.

    Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A;

    French Society for Childhood Cancer (SFCE). Radiother Oncol. 2018 Feb 27. pii: S0167-8140(18)30064-1. doi: 10.1016/j.radonc.2018.02.008.
  • > 44- Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.

    Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, Laprie A, Cohen-Jonathan Moyal E, Lubrano V.

    Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7.
  • > 6- Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma

    Fatima Tensaouti, Anne Ducassou, Léonor Chaltiel, Stéphanie Bolle, Xavier Muracciole, Bernard Coche-Dequeant, Claire Alapetite, Valérie Bernier, Line Claude, Stéphane Supiot, Aymeri Huchet, Christine Kerr, Elisabeth le Prisé, Anne Laprie

    Anne Laprie RadiotherOncol (2017),http://dx.doi.org/10.1016/j.radonc.2016.12.025
  • > 21- Subventricular zones: new key targets for glioblastoma treatment.

    Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, Uro-Coste E, Lubrano V, Cohen-Jonathan Moyal E.

    Radiat Oncol. 2017 Apr 20;12(1):67. doi: 10.1186/s13014-017-0791-2.
  • > 52- Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma.

    Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Muracciole X, Coche-Dequeant B, Alapetite C, Bernier V, Claude L, Supiot S, Huchet A, Kerr C, le Prisé E, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE).

    Radiother Oncol. 2017 Mar;122(3):362-367. doi: 10.1016/j.radonc.2016.12.025. Epub 2017 Jan 12.
  • > 41- Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.

    Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A.

    Eur Radiol. 2016 Nov;26(11):4194-4203.
  • > 53- Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.

    Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE)..

    Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537.
  • > 59- Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

    Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A.

    J Neurooncol. 2016 Oct;130(1):181-192.